Andujar, Jellou .

HRN: 28-34-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/28/2025
01/04/2026
IV
490mg
Q6h
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines